Patent Assignment
Reel/Frame 027108/0381
Release of Security Interest in Patents
Recorded: 2011-10-24
Pages: 4
Assignor
SILVER POINT FINANCE, LLC
Executed: 2011-10-21
Assignee
XANDODYNE PHARMACEUTICALS, INC.
ONE RIVERFRONT PLACE, NEWPORT, KENTUCKY, 41070
Covered Properties
(11)
Tranexamic Acid Formulations with Reduced Adverse Effects
PCT:
PCT/US2004/023528 ↗
N-Desmethyl Levomepromazine
PCT:
PCT/US2004/032956 ↗
A Stable Parenteral Formulation of Levomepromazine and a Method for Stabilizing Said Formulation
PCT:
PCT/US2005/003656 ↗
Enteric coated caffeine tablet
Application:
10/154,629 →
Publication:
US 2003/0220351
Vitamin/Mineral Compositions with Dha
Compositions with improved stability and methods of formulation thereof
Application:
10/375,391 →
Publication:
US 2004/0170687
Prenatal Multivitamin/Multimineral Supplement
Tranexamic acid formulations with reduced adverse effects
Application:
10/631,371 →
Publication:
US 2005/0025825
N-desmethyl levomepromazine
Application:
10/681,431 →
Publication:
US 2005/0080076
Tranexamic acid formulations
Application:
11/072,162 →
Publication:
US 2005/0245614
Tranexamic acid formulations
Application:
11/072,194 →
Publication:
US 2005/0244495
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.